KORU Medical Systems, Inc. (NASDAQ:KRMD) Given Average Recommendation of “Moderate Buy” by Analysts

KORU Medical Systems, Inc. (NASDAQ:KRMD) has been given a consensus rating of “Moderate Buy” by the six ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, one has issued a hold rating, three have assigned a buy rating and one has assigned a strong buy rating to the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is $5.1250.

A number of research analysts recently commented on the company. Canaccord Genuity Group set a $6.00 price target on KORU Medical Systems and gave the stock a “buy” rating in a research report on Wednesday. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of KORU Medical Systems in a report on Wednesday, October 8th.

KORU Medical Systems Stock Down 5.3%

Shares of KRMD traded down $0.31 on Wednesday, hitting $5.47. The company’s stock had a trading volume of 49,708 shares, compared to its average volume of 172,944. The firm’s fifty day moving average price is $4.66 and its 200-day moving average price is $4.03. KORU Medical Systems has a fifty-two week low of $1.86 and a fifty-two week high of $6.11. The company has a quick ratio of 1.92, a current ratio of 2.48 and a debt-to-equity ratio of 0.01. The firm has a market capitalization of $253.14 million, a price-to-earnings ratio of -68.31 and a beta of 0.58.

Institutional Investors Weigh In On KORU Medical Systems

Hedge funds and other institutional investors have recently bought and sold shares of the company. Connor Clark & Lunn Investment Management Ltd. increased its position in shares of KORU Medical Systems by 11.8% during the first quarter. Connor Clark & Lunn Investment Management Ltd. now owns 66,917 shares of the company’s stock worth $170,000 after buying an additional 7,046 shares during the period. HighTower Advisors LLC boosted its position in KORU Medical Systems by 18.4% during the first quarter. HighTower Advisors LLC now owns 51,400 shares of the company’s stock valued at $131,000 after acquiring an additional 8,000 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in KORU Medical Systems by 220.5% during the 1st quarter. Russell Investments Group Ltd. now owns 214,908 shares of the company’s stock worth $546,000 after acquiring an additional 147,857 shares during the period. OMERS ADMINISTRATION Corp acquired a new stake in KORU Medical Systems during the 1st quarter worth about $239,000. Finally, Cubist Systematic Strategies LLC raised its position in shares of KORU Medical Systems by 927.4% in the 1st quarter. Cubist Systematic Strategies LLC now owns 77,280 shares of the company’s stock worth $196,000 after acquiring an additional 69,758 shares in the last quarter. Institutional investors own 58.60% of the company’s stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.